Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of shivering during combined spinal epidural anaesthesia for elective caesarean section
ACTRN12609000445279Phase 3Completed
- Sponsor
- Dr Roger Browning
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron (2 arms), sponsored by Dr Roger Browning. Primary endpoint: Incidence of shivering. Started Jun 2009; status: completed.
02
Drugs
ondansetron
Beyond the preview
Go deeper on ACTRN12609000445279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000445279.